ContextVision AB

CONTX · Oslo Børs · Healthcare

5.20NOK −1.9%last day

Price as of 2 October 2026

The price over the past year, with dividends: +13.0%

Performance

1 month

+21.8%

1 year

+13.0%

3 years, per year

−9.6%

5 years, per year

−26.0%

Largest fall, 3 years

−79.7%

Below the peak now

−80.7%

Volatility, 1 year

58.7%

Return with dividends reinvested.

Key figures

P/E

29.6

P/B

3.9

Dividend yield

0.0%

Return on equity

+13.3%

Net margin

+11.1%

Market value

40 m USD

Quality, value and trend

Where ContextVision stands against every Nordic stock today. 100 is best.

Quality79

Profitability and a sound balance sheet over time. Better than 79% of Nordic stocks.

Value28

The price measured against earnings, assets and cash flow. Better than 28% of Nordic stocks.

Trend85

The price development over the past year. Better than 85% of Nordic stocks.

Combined77

Quality, value and trend together. Better than 77% of Nordic stocks.

About ContextVision

ContextVision AB is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 39 employees.

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis